Artesian VC

Artesian VC is an alternative investment management company that specializes in early-stage venture capital, particularly in the clean energy sector. Established in 2004 after spinning out from ANZ Banking Group, the company has evolved to manage a range of specialized funds, with a focus on seed and follow-on investments in startups sourced from approved accelerators, incubators, and academic programs. Artesian's investment strategy emphasizes partnerships with leading organizations in the startup ecosystem, enabling it to identify and support high-potential ventures. With offices in Sydney, Melbourne, Shanghai, New York, London, and Singapore, the company has built a global presence and has successfully raised over AUD 255 million for its various funds. Additionally, Artesian has expanded its reach through initiatives like its China VC Fund and plans for a Southeast Asia VC Fund, underscoring its commitment to fostering innovation in diverse markets.

Matthew Clunies-Ross

Managing Partner

Tim Heasley

Partner and COO

Felix Zhang

Partner

Past deals in Hospital

Vantari VR

Series A in 2023
Vantari VR develops a virtual reality simulation platform for procedural training in medicine and surgery that is designed for hospitals, universities, and medical device companies, combines medical imaging with immersive VR to visualize and interpret complex images, provides VR training that allows doctors to practice procedures in a safe, scalable environment to reduce medical errors, and enables surgeons to rehearse and plan operational steps, supporting informed decision-making and contributing to improved patient outcomes.

VitalTrace

Series A in 2023
VitalTrace is a medical device company focused on enhancing the childbirth experience for mothers, clinicians, and infants through innovative monitoring technology. The company has developed a novel biosensor device that assists in monitoring potential complications during labor and delivery. By providing real-time data, this device empowers obstetricians to administer appropriate treatments, ultimately improving outcomes in the obstetric field. VitalTrace aims to support healthcare professionals in delivering safer and more effective care during one of life’s most critical moments.

Lenexa Medical

Seed Round in 2021
Lenexa Medical specializes in developing innovative technology aimed at preventing pressure injuries in hospitalized patients. Their core product is a medical-grade smart sheet, an ultra-thin fabric bedsheet equipped with advanced sensing capabilities. This sheet, when used in conjunction with Lenexa's proprietary software, continuously monitors patient position and posture, thereby assessing the risk of pressure injuries. The company's services focus on providing clinicians with actionable insights to deliver targeted, long-term solutions for pressure injury detection and prevention, ultimately enhancing patient health outcomes.

Curatek

Venture Round in 2021
Curatek is a medical device company focused on improving patient outcomes and enhancing hospital efficiency through early detection of clinical deterioration. The company's primary product is a wireless disposable patch that continuously monitors a patient's respiratory rate. By providing real-time data, this device enables clinicians to identify potential health issues early, thereby preventing adverse events such as cardiac arrest, unexpected death, and unplanned admissions to intensive care units. Curatek's innovative approach aims to save lives by facilitating timely interventions in critical healthcare settings.

UpperMed

Seed Round in 2020
UpperMed develops home dialysis technology centered on a portable peritoneal dialysis device that lets patients perform dialysis at home with greater flexibility. The device automatically records metrics such as flow rate and volume and syncs data to a companion app, supporting automatic records and monitoring. The company markets the device directly to consumers while charging for the app, and plans to expand by offering hospital management system integrations to support organizational use.

The CareVoice

Series A in 2019
The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.

NeedleCalm

Venture Round in 2019
NeedleCalm is a medical device company that aims to reduce pain and anxiety associated with needle-related procedures in hospital settings. Its technology targets both patients and healthcare providers by minimizing discomfort during injections and blood draws, thereby improving patient comfort, staff satisfaction, and adherence to clinical guidelines. The solution is designed to streamline workflow and conserve time and resources in needle-related care.

Scrubit

Seed Round in 2017
Scrubit is a software company specializing in streamlining hospital operating suite processes. Its flagship product is an intuitive app that automates and manages theatre setup, creating customizable checklists for staff, ensuring all necessary equipment and instruments are readily available for surgeries. Additionally, Scrubit offers modules for anesthesia management, critical care, clinical documentation, patient tracking, and analytics, providing real-time, user-friendly data to enhance operational efficiency and reduce manual data entry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.